Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Designer genes and anti-anxiety drugs

Nature Neuroscience volume 3, pages 529–530 (2000)Cite this article

Anxiolytic-like and sedative effects of benzodiazepines can be dissociated in mice with a mutant GABAA receptor α1 subunit gene or in wild-type mice by a new benzodiazepine-site ligand.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Contribution of α1 subunit-containing GABAA receptors to the effects of benzodiazepine-site ligands.

References

  1. Horwath, E. & Weissman, M. M. in Comprehensive Textbook of Psychiatry Vol. 1, 7th Ed. (eds. Sadock, B. J. & Sadock, V. A.) 1444–1450 (Lippincott, Williams and Wilkins, New York, 2000).

    Google Scholar 

  2. Ballenger, J. C. in Comprehensive Textbook of Psychiatry Vol. 1, 7th Ed. (eds. Sadock, B. J. & Sadock, V. A.) 2317–2323 (Lippincott, Williams and Wilkins, New York, 2000).

    Google Scholar 

  3. Rudolph, U. et al. Nature 401, 796–800 (1999).

    Article  CAS  Google Scholar 

  4. McKernan, R. et al. Nat. Neurosci. 3, 587–592 (2000).

    Article  CAS  Google Scholar 

  5. Sigel, E. & Buhr, A. Trends Pharmacol. Sci. 18, 425–429 (1997).

    Article  CAS  Google Scholar 

  6. Sieghart, W. Pharmacol. Rev. 47, 181–234 (1995).

    CAS  Google Scholar 

  7. Wieland, H. A., Lüddens, H. & Seeburg, P. H. J. Biol. Chem. 267, 1426–1429 (1992).

    CAS  PubMed  Google Scholar 

  8. Benson, J. A., Löw, K., Keist, R., Mohler, H. & Rudolph, U. FEBS Lett. 431, 400–404 (1998).

    Article  CAS  Google Scholar 

  9. Kleingoor, C., Wieland, H. A., Korpi, E. R., Seeburg, P. H. & Kettenmann, H. Neuroreport 4, 187–190 (1993).

    Article  CAS  Google Scholar 

  10. Fritschy, J. M. & Mohler, H. J. Comp. Neurol. 359, 154–194 (1995).

    Article  CAS  Google Scholar 

  11. Lister, R. G. Pharmacol. Ther. 46, 321–340 (1990).

    Article  CAS  Google Scholar 

  12. Crabbe, J. C., Wahlsten, D. & Dudek, B. C. Science 284, 1670–1672 (1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of California, San Francisco, 401 Parnassus Ave., San Francisco, 94143-0984, California, USA

    Laurence H. Tecott

Authors
  1. Laurence H. Tecott
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tecott, L. Designer genes and anti-anxiety drugs. Nat Neurosci 3, 529–530 (2000). https://doi.org/10.1038/75692

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/75692

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing